Gene · 1031
Papers2,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,553
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic effects of herbal medicine. | Clin Epigenetics | 2023 | 37179342 | PubTator, text mining | PubMed |
| A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2. | Hereditas | 2023 | 37170390 | PubTator, text mining | PubMed |
| Activity of pemetrexed in pre-clinical chordoma models and humans. | Sci Rep | 2023 | 37147496 | PubTator, text mining | PubMed |
| Polypyrimidine tract binding protein 1 (PTBP1) contains a novel regulatory sequence, the rBH3, that binds the prosurvival protein MCL1. | J Biol Chem | 2023 | 37142223 | PubTator, text mining | PubMed |
| Update on the current management of persistent and recurrent primary hyperparathyroidism after parathyroidectomy. | World J Clin Cases | 2023 | 37122518 | PubTator, text mining | PubMed |
| Pituitary Tumorigenesis-Implications for Management. | Medicina (Kaunas) | 2023 | 37109772 | PubTator, text mining | PubMed |
| Spheroids as a model for endometriotic lesions. | JCI Insight | 2023 | 37104033 | PubTator, text mining | PubMed |
| Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 | 37093270 | PubTator, text mining | PubMed |
| Identification of Serum miR-501-3p and miR-338-3p as Novel Diagnostic Biomarkers for Breast Cancer and Their Target Genes Associated with Immune Infiltration. | Int J Gen Med | 2023 | 37077765 | PubTator, text mining | PubMed |
| A novel immune score model predicting the prognosis and immunotherapy response of breast cancer. | Sci Rep | 2023 | 37076508 | PubTator, text mining | PubMed |
| PAXIP1 and STAG2 converge to maintain 3D genome architecture and facilitate promoter/enhancer contacts to enable stress hormone-dependent transcription. | Nucleic Acids Res | 2023 | 37070193 | PubTator, text mining | PubMed |
| The digital expression profile of BMP7, CDKN2C, HIST1H3G, and PKMYT1 genes improves high-grade cervical lesion detection in liquid-based cytology. | Cancer Cytopathol | 2023 | 37069588 | PubTator, text mining | PubMed |
| CDK regulators-Cell cycle progression or apoptosis-Scenarios in normal cells and cancerous cells. | Adv Protein Chem Struct Biol | 2023 | 37061330 | PubTator, text mining | PubMed |
| The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. | Cells | 2023 | 37048102 | PubTator, text mining | PubMed |
| Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract-Comparison of the Risk Factors and Non-Surgical Treatment Efficacy. | Int J Mol Sci | 2023 | 37047829 | PubTator, text mining | PubMed |
| CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective. | Front Cell Dev Biol | 2023 | 37035239 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37008945 | PubTator, text mining | PubMed |
| miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. | J Immunol Res | 2023 | 37008632 | PubTator, text mining | PubMed |
| Plasma cell myeloma initially diagnosed as light-chain deposition disease on liver biopsy: A case report and literature review. | Medicine (Baltimore) | 2023 | 37000077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1031/papers?page=10